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Background: Traumatic brain injury (TBI) initiates a neuroinflammatory cascade that contributes to substantial neuronal
damage and behavioral impairment, and Toll-like receptor 4 (TLR4) is an important mediator of thiscascade. In the
current study, we tested the hypothesis that curcumin, a phytochemical compound with potent anti-inflammatory
properties that is extracted from the rhizome Curcuma longa, alleviates acute inflammatory injury mediated by TLR4
following TBI.
Methods: Neurological function, brain water content and cytokine levels were tested in TLR4−/− mice subjected to
weight-drop contusion injury. Wild-type (WT) mice were injected intraperitoneally with different concentrations of
curcumin or vehicle 15 minutes after TBI. At 24 hours post-injury, the activation of microglia/macrophages and TLR4
was detected by immunohistochemistry; neuronal apoptosis was measured by FJB and TUNEL staining; cytokines were
assayed by ELISA; and TLR4, MyD88 and NF-κB levels were measured by Western blotting. In vitro, a co-culture system
comprised of microglia and neurons was treated with curcumin following lipopolysaccharide (LPS) stimulation. TLR4
expression and morphological activation in microglia and morphological damage to neurons were detected by
immunohistochemistry 24 hours post-stimulation.
Results: The protein expression of TLR4 in pericontusional tissue reached a maximum at 24 hours post-TBI. Compared
with WT mice, TLR4−/− mice showed attenuated functional impairment, brain edema and cytokine release post-TBI.
In addition to improvement in the above aspects, 100 mg/kg curcumin treatment post-TBI significantly reduced the
number of TLR4-positive microglia/macrophages as well as inflammatory mediator release and neuronal apoptosis in
WT mice. Furthermore, Western blot analysis indicated that the levels of TLR4 and its known downstream effectors
(MyD88, and NF-κB) were also decreased after curcumin treatment. Similar outcomes were observed in the microglia and
neuron co-culture following treatment with curcumin after LPS stimulation. LPS increased TLR4 immunoreactivity and
morphological activation in microglia and increased neuronal apoptosis, whereas curcumin normalized this upregulation.
The increased protein levels of TLR4, MyD88 and NF-κB in microglia were attenuated by curcumin treatment.
Conclusions: Our results suggest that post-injury, curcumin administration may improve patient outcome by reducing
acute activation of microglia/macrophages and neuronal apoptosis through a mechanism involving the TLR4/MyD88/
NF-κB signaling pathway in microglia/macrophages in TBI.
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Traumatic brain injury (TBI) is defined as damage to the
brain resulting from an external mechanical force, which
can lead to temporary or permanent impairment of cog-
nitive, physical and psychosocial functions [1]. It is the
leading cause of death and disability for people under
the age of 45 years. Ten million deaths and/or hospitali-
zations annually are directly attributable to TBI, and an
estimated 57 million living people worldwide have expe-
rienced such brain injury [2].
It is well known that TBI is a highly complex disorder
that is caused by both primary and secondary brain in-
jury mechanisms. Secondary brain injury, which results
from delayed neurochemical, metabolic and cellular
changes, can evolve over hours to days after the initial
traumatic insult and cause progressive white and gray
matter damage. A complex series of sterile inflammatory
responses play an important role in secondary brain in-
jury following TBI [3,4]. However, a detailed understand-
ing of the effect of innate immunity after TBI remains
limited at present. The innate immune system recognizes
different pathogens via highly conserved microbial motifs,
namely pathogen-associated molecular patterns (PAMPs),
through pathogen-recognition receptors (PRRs) [5]. Toll-
like receptors (TLRs) are a family of PRRs that recognize
conserved microbial motifs in molecules such as bacterial
lipopolysaccharide (LPS), peptidoglycan, flagellin, and
double- and single-stranded viral RNAs. Recently, it has
been shown that TLRs become activated in response to
endogenous ligands released during tissue injury, such as
the degradation products of macromolecules, heat shock
proteins and intracellular components of ruptured cells,
known as damage-associated molecular patterns (DAMPs)
[6]. Microglia, the principal cells involved in the innate im-
mune response in the CNS, express robust levels of TLR1-
9 [7]. Among these TLRs, TLR4 has been shown to play
an important role in initiating the inflammatory response
following stroke or head trauma [8-10]. Furthermore,
myeloid differentiation factor 88 (MyD88), a critical
adapter protein for TLR4, leads to the activation of down-
stream NF-κB and the subsequent production of proin-
flammatory cytokines implicated in neurotoxicity [11,12].
Curcumin, a major component extracted from the rhi-
zome Curcuma longa, has been consumed by humans as
a curry spice for centuries. It has been extensively stud-
ied for its wide range of biological activities, including
anti-inflammatory, anti-oxidant, anti-infection and anti-
tumor properties [13]. In vivo, curcumin has been found
to cross the blood-brain barrier and maintain high bio-
logical activity [14], and it has been proposed for the
treatment of various neuroinflammatory and neurode-
generative conditions in the CNS. Recent studies have
demonstrated that curcumin is a highly pleiotropic mol-
ecule that interacts with numerous molecular targets[15]. Thus far, although a few studies indicate that curcu-
min can attenuate cerebral edema, promote membrane
and energy homeostasis and influence synaptic plasticity
following TBI [16-19], the modulatory effects of curcumin
on the inflammatory response after TBI remain largely
unknown. Recently, in vitro, curcumin has been shown to
inhibit the homodimerization of TLR4, which is required
for the activation of downstream signaling pathways
[20,21]. The presumption that curcumin can attenuate in-
flammatory injury via the TLR4 pathway has since been
tested in some models of injury [22-25], but it remains un-
known whether exogenous curcumin can modulate TBI
through the TLR4/MyD88/NF-κB signaling pathway. We
designed this study to investigate the importance of TLR4
in initiating the acute inflammatory response following
TBI, which contributes to neuronal damage and be-
havioral impairment, and to confirm the hypothesis that
curcumin attenuates acute inflammatory damage by
modulating the TLR4/MyD88/NF-κB signaling pathway in
microglia/macrophages during experimental TBI.
Materials and methods
Animals
Adult male C57BL/6 mice (8 to 10 weeks, 20 to 25 g)
were provided by the Animal Center of Third Military
Medical University. Transgenic TLR4−/− mice (8 to 10
weeks, 20 to 22 g) were purchased from Jackson Labora-
tories (Bar Harbor, ME, USA) and were backcrossed to a
C57BL/6 background more than eight times. All experi-
ments were conducted in accordance with animal care
guidelines approved by the Animal Ethics Committee of
the Third Military Medical University. The animals were
housed in temperature- and humidity-controlled animal
quarters with a 12-hour light/dark cycle and water and
food provided ad libitum. Mice were treated with an in-
traperitoneal injection of curcumin (Sigma, St. Louis,
MO, USA) dissolved in 100 μL of dimethyl sulfoxide
(DMSO) (50, 100, 200 mg/kg) or equal volumes of ve-
hicle 15 minutes post-TBI. In our experiment, each test
was performed independently for either three times
(three mice per group) or twice (six mice per group).
Experimental traumatic brain injury model in mice
TBI was induced using a Feeney weight-drop contusion
model with slight modifications [26]. Mice were anesthe-
tized with intraperitoneal chloral hydrate (40 mg/kg) and
placed in a stereotaxic frame, and a 4 mm craniotomy was
performed over the right parietal cortex, centered on the
coronal suture and 3 mm lateral to the sagittal suture.
Considerable care was taken to avoid injury to the under-
lying dura. A weight-drop device was placed over the dura.
An impact transducer (foot plate) was adjusted to stop at
a depth of 2.5 mm below the dura. Then, one 18 g weight
was dropped from 10 cm above the dura through a guide
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with an overhead heating lamp during the experiments.
Dural tears were not repaired and the bone flap was not re-
inserted. If the animals demonstrated dural tears or exces-
sive bleeding, they were excluded. After injury, the skin was
closed tightly. To maintain normal body temperature dur-
ing surgery and recovery, the mice were maintained with
isothermic (37°C) heating. Mice in the sham-operation
group were subjected to the same surgical procedure,
including craniotomy, but received no cortical impact.
Neurological function evaluation
Behavioral testing was performed one day after TBI using
the mNSS (modified Neurological Severity Score) assess-
ment. The mNSS is a composite of motor, sensory, reflex
and balance tests [27]. One point was scored for the in-
ability to perform each test or for the lack of a tested re-
flex; thus, the higher the score was, the more severe the
injury. Neurological function was graded on a scale of 0 to
18 (normal score, 0; maximal deficit score, 18).
Brain water content
Twenty-four hours post-injury, brain edema was deter-
mined using the wet/dry method:
Percent brain water = [(Wet weight–Dry weight)/Wet
weight] · 100% [28]
The brains from mice in each treatment group were
rapidly removed from the skull, and the brains were sep-
arated bilaterally, weighed and then placed in an oven
for 72 hours at 100°C. The brains were then reweighed
to obtain dry weight content.
Cortical neuronal cultures
Cortical cells were prepared from embryonic day 15
pregnant mice. Briefly, embryos were removed, the cere-
bral cortex was dissected, and meninges were stripped in
Ca2+/Mg2+-free Hank’s balanced saline solution (HBSS)
solution. Tissues were then digested in 0.125% trypsin
for 15 minutes and dispersed through the narrowed bore
of a fire-polished Pasteur pipette and passed through a
40 μm cell strainer. Cells were distributed in a poly-L-
lysine-coated (Sigma) culture plate containing 0.5 mL of
neurobasal medium with 2% B27 supplement (Invitro-
gen, Carlsbad, CA, USA). The culture density was 5 ×
105 cells/mL. Cultures were maintained at 37°C in a
humidified incubator with 5% CO2/95% room air. All
transwell co-culture experiments were performed with
neurons that had been in culture for seven days.
Microglial cultures
The cortices of the cerebral hemispheres of one-day-old
post-natal mice were dissected and digested with 0.25%trypsin. After centrifugation for five minutes at 300 × g,
the cortical cells were seeded in DMEM-F12 with 10%
FBS on a 25 cm2 flask at a density of 3 × 105 cells/mL
and cultured at 37°C in humidified 5% CO2/95% air. The
medium was replaced every four to five days, and con-
fluency was achieved after 14 days in vitro. Microglial
cells were obtained by shaking the flasks overnight. Float-
ing cells were pelleted and subcultured at 3 × 105 cells/mL
in glial-conditioned medium on poly-L-lysine pre-coated
transwell inserts. Cell purity was determined by immuno-
histochemical staining with microglia-specific antibodies
for CD11b, and purity was determined to be > 95%.
Transwell co-cultures
Transwell co-cultures were performed as previously
described [29]. Microglia were plated onto the top side
of the transwell inserts (0.4 μm pore size polyester
membrane precoated with poly-L-lysine; Corning, NY,
USA) at the cell density described above. The transwells
were positioned approximately 2 mm above the neuron-
enriched culture plate, and the microglia grown on the
transwells were separated from the neurons by the per-
meable transwell membrane. Then, 1 μg/ml LPS (Sigma,
St. Louis, MO, USA), curcumin, LPS plus curcumin or
DMSO (Sigma, St. Louis, MO, USA) as a solvent control
was added to the media below the transwells.
Cytotoxicity assay
Cell viability was evaluated by the 3-(4,5-dimethyl-
thiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) re-
duction assay. In brief, neurons (5 × 105 cells/mL) and
microglia (3 × 105 cells/mL) were seeded in the transwell
system, as described above, and treated with various
concentrations of curcumin. After 24 hours of incuba-
tion, the medium was removed. The neurons and micro-
glia were separated and then incubated with 0.5 mg/mL
MTT solution. After incubation for three hours at 37°C
in 5% CO2, the supernatant was removed, and the for-
mation of formazan crystals was measured at 490 nm
with a microplate reader.
Immunofluorescence
Mice were perfused transcardially with saline, followed
by 4% paraformaldehyde under deep anesthesia (100
mg/kg sodium pentobarbital) and their brains sectioned
at a 20 μm thickness using a cryostat. The sections were
blocked in 5% normal donkey serum diluted in PBS for
one hour at room temperature and then incubated over-
night at 4°C with mouse anti-TLR4 or rat anti-CD11b as
the primary antibody. Donkey anti-mouse Alexa-Fluor
568 and donkey anti-rat Alexa-Fluor 488 were used as
secondary fluorescent probes. The sections were viewed
by confocal microscopy (LSM780, Zeiss, Jena, Germany)
and analyzed as individual images for TLR4 and CD11b
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tively characterized by digital image analysis using Image
Pro-Plus 6.0 software (Media Cybernetics, Silver Spring,
MD, USA). TLR4 was quantified as the average number
of positive cells per field. A negative (no antibody) con-
trol was included.
Cell cultures were fixed for 30 minutes in 4% parafor-
maldehyde. Cells were blocked with 1% bovine serum
for one hour. Cultures were incubated overnight at 4°C
with primary antibody. Microglia were incubated with
mouse anti-TLR4 (1:400, ab22048;Abcam, Cambridge,
MA, USA) or rat anti-CD11b (1:200, ab8878;Abcam,
Cambridge, MA, USA). Neurons were incubated with
mouse anti-tubulin (1:400, MAB1637; Millipore, Billerica,
MA, USA). Alexa 488 and Alexa 568 secondary fluores-
cent antibodies (1:400, Invitrogen, Carlsbad, CA, USA)
were used for one hour at 37°C, and the nuclei were
stained with 4',6-diamidino-2-phenylindole(DAPI) for ten
minutes. The cells were observed by confocal microscopy.
The images were analyzed individually to evaluate TLR4
and CD11b co-expression, and the immunofluorescence
intensity of TLR4 per field was determined using Image
Pro-Plus 6.0 software(Media Cybernetics, Silver Spring,
MD, USA). A negative (no antibody) control was included.
Western blot analysis
Protein was extracted from the cortex surrounding the
injured area and cultured microglia or neurons using a
protein extraction kit (P0027, Beyotime Biotech,Jiangsu,
China). The lysate was separated by centrifugation at
12,000 × g at 4°C for 15 minutes, and the supernatant
was collected. The protein concentration was deter-
mined using a BCA assay kit (P0010, Beyotime Biotech,
Jiangsu, China). Nuclear protein (for NF-κB p65) and
other cytoplasmic proteins were diluted in the loading
buffer and subjected to sodium dodecyl sulfate polyacry-
lamidegel electrophoresis(SDS-PAGE) followed by trans-
fer to PVDF membranes. The membrane was blocked
with 5% freshly prepared milk-TBST for two hours at
room temperature and then incubated overnight at 4°C
with the following primary antibodies: mouse anti-TLR4
(1:400, ab22048;Abcam, Cambridge, MA, USA), rabbit
anti-MyD88 (1:400, ab2064;Abcam, Cambridge, MA,
USA), mouse anti-NF-κB (1:400, sc-8008; Santa Cruz
Biotechnology Inc., Santa Cruz, CA, USA), rabbit anti-
cleaved caspase-3 (1:400, 9661; CST, Danvers, MA, USA),
rabbit anti-IκB-α (1:400, sc-371; Santa Cruz Biotechnology
Inc., Santa Cruz, CA, USA), mouse anti-phosphorylated-
IκB-α (1:400, sc-8404; Santa Cruz Biotechnology Inc.,
Santa Cruz, CA, USA, USA) and β-actin (1:1,000, AA128;
Beyotime Biotech, Jiangsu, China). After the membrane
was washed in TBST, it was incubated in the appropriate
AP-conjugated secondary antibody (diluted 1:2,000 in sec-
ondary antibody dilution buffer) for one hour at 37°C.Protein bands were visualized by nickel-intensified DAB
solution according to previous reports [30]. The β-actin
antibody was used as an internal standard. The optical
densities of the detected proteins were obtained using
Image Pro-Plus software 6.0 (Media Cybernetics, Silver
Spring, MD, USA).
Enzyme-linked immunosorbent assay (ELISA)
Brain tissue in the cerebral cortex around the injured
area was collected and homogenized. The homogenates
were centrifuged at 4°C at 12,000 × g for 15 minutes,
and supernatants were collected carefully and evaluated
in duplicate using IL-1β, IL-6, TNF-α, MCP (monocyte
chemoattractant protein)-1 and RANTES (regulated
upon activation, normal T cell expressed and secreted)
assay kits (R&D Systems, Minneapolis, MN, US), in
accordance with the manufacturer’s guidelines. Tissue
cytokine concentrations are expressed as picograms per
milligram of protein.
Cell culture supernatants were carefully collected at 24
hours after stimulation with LPS and centrifuged at 4°C
at 12,000 × g for 15 minutes. Cytokine concentrations
were evaluated using protein assay kits (R&D Systems,
Minneapolis, MN, US), in accordance with the manufac-
turer’s guidelines. Cell cytokine concentrations are
expressed as picograms per milliliter.
FJB histochemistry
Fluoro-Jade B (FJB) is a polyanionic fluorescein deriva-
tive that binds with high sensitivity and specificity to de-
generating neurons. FJB staining of brain sections was
performed as previously described with slight modifica-
tions [31]. Briefly, selected sections were first incubated
in a solution of 1% NaOH in 80% ethanol for five mi-
nutes and then rehydrated in 70% ethanol and distilled
water for two minutes each. The sections were then in-
cubated in 0.06% KMnO4 for ten minutes, rinsed in dis-
tilled water for two minutes and incubated in a 0.0004%
solution of FJB (Chemicon, Temecula, CA, USA) for 20
minutes. Sections were observed and photographed
under a confocal microscope.
TUNEL staining
The TUNEL assay was performed using a commercial kit
that labels DNA strand breaks with fluorescein isothio-
cyanate (FITC; In Situ Cell Death Detection Kit, Roche
Molecular Biochemicals, Mannheim, Germany). Selected
sections were pretreated with 20 mg/mL proteinase-K in
10 mM Tris-HCl at 37°C for 15 minutes. These sections
were then rinsed in PBS and incubated in 0.3% hydrogen
peroxide dissolved in anhydrous methanol for ten mi-
nutes. The sections were then incubated in 0.1% sodium
citrate and 0.1% Triton X-100 solution for two minutes at
2 to 8°C. After several washes with PBS, sections were
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terminal deoxynucleotidyltransferase (TdT) for 60 mi-
nutes at 37°C under humidified conditions, and neuronal
nuclei were stained with DAPI. Each section was observed
and photographed under a confocal microscope. Negative
controls were obtained by omitting the TdT enzyme.
Statistical analysis
All data are presented as the mean ± SD. SPSS 11.5 was
used for statistical analysis of the data. Two-way
repeated-measures ANOVAs with LSD posthoc tests
were used to determine statistical significance between
behavioral measures. One-way ANOVAs with the appro-
priate LSD posthoc tests were used to compare experi-
mental groups. For all analyses, P < 0.05 was considered
significant.
Results
Time-dependent protein expression of TLR4
A coronal brain slice showed an obvious cavity in the in-
jured cortex, which was surrounded by hemorrhage. The
tissue examined in the experiment is indicated by a box
in the figure (Figure 1A). Basal TLR4 expression was
low in the sham control brains. The expression of TLR4
was significantly increased in the injured tissue at six
hours post-trauma (P < 0.05) and reached a maximum at
24 hours (P < 0.01); thereafter, it decreased but remained
high through 72 hours post-TBI (P < 0.05) (Figure 1B).
TLR4 deficiency attenuated neurological deficit, cerebral
edema, cytokine release and cell death post-trauma
To confirm the role of TLR4 in TBI, TLR4−/− mice were
used to investigate cerebral edema, neurological function
impairment and the release of cytokines post-trauma in
comparison with WT mice. The neurological deficit
score of TLR4−/− mice was significantly lower than
that of WT mice at 24 hours post-trauma (P < 0.05,
Figure 1C). The brain water content of TLR4−/− mice
was also significantly lower than that of WT mice at 24
hours post-trauma (P < 0.05, Figure 2A). Moreover, the
IL-1β, IL-6, MCP-1 and RANTES protein concentra-
tions in the injured brain tissue, as determined by
ELISA, were also significantly decreased in TLR4−/−
mice compared with WT mice (P < 0.05, Figure 2B, C, E,
F), but the TNF-α concentration was not significantly
different between TLR4−/− and WT mice (P > 0.05,
Figure 2D). In addition, neuronal and apoptotic cell
death were alleviated in TLR4−/− mice. Both FJB-positive
cells with neuronal morphology and TUNEL-positive
cells were evident 24 hours post-trauma in the pericon-
tusional tissue (Figure 1D, E). The number of TUNEL-
positive cells increased dramatically around the injured
tissue in the TBI groups at 24 hours post-trauma.
However, significantly fewer TUNEL-positive cells werefound in TLR4−/− mice than in WT mice (P < 0.05,
Figure 1F). Furthermore, TLR4−/− mice also had signifi-
cantly fewer FJB-positive neurons in the pericontusional tis-
sue when compared with WT mice (P < 0.05, Figure 1G).
Downregulation of TLR4 expression by curcumin
treatment post-trauma
Because TLR4 deficiency resulted in neuroprotection, we
next examined the effects of curcumin on TLR4 protein
expression. We administered different concentrations of
curcumin (50, 100, or 200 mg/kg) to mice fifteen mi-
nutes post-TBI and examined TLR4 expression 24 hours
post-trauma. The administration of 50 mg/kg curcumin
did not significantly reduce TLR4 expression compared
with TBI alone (P > 0.05, Figure 3A). In contrast, 100
mg/kg or 200 mg/kg curcumin significantly reduced
TLR4 expression (P < 0.01 versus TBI alone), but TLR4
expression did not significantly differ between these two
groups (P > 0.05). Accordingly, 100 mg/kg was selected
due to the dramatic reduction of TLR4 expression and
the relatively low concentration of curcumin.
Neuroprotection of curcumin post-trauma
Curcumin attenuated cerebral edema and improved
neurological function following TBI. The neurological
deficit scores were significantly lower in curcumin-
treated mice than in vehicle-treated mice at 24 hours
post-trauma (P < 0.05, Figure 3B). Brain water content
was significantly decreased in curcumin-treated mice
when compared with vehicle-treated mice at 24 hours
post-trauma (P < 0.05, Figure 3C). In addition, curcumin
reduced neuronal and apoptotic cell death. Both FJB-
positive cells with neuronal morphology and TUNEL-
positive cells were evident 24 hours post-trauma in the
pericontusional tissue (Figure 3D, E). The number of
TUNEL-positive cells was increased dramatically around
the injured tissue in the TBI groups at 24 hours post-
trauma. Significantly fewer TUNEL-positive cells were
found in curcumin-treated mice than in vehicle-treated
mice (P < 0.05, Figure 3F). Furthermore, curcumin-
treated mice also had significantly fewer FJB-positive
neurons in the pericontusional tissue than did the
vehicle-treated group (P < 0.05, Figure 3G).
Curcumin inhibited the activation of TLR4-positive micro-
glia/macrophages and inflammatory mediator release in
injured tissue
In the pericontusional tissue of sham control mice, a few
quiescent microglia with small cell bodies and fine, rami-
fied processes were observed 24 hours post-trauma. Few
or no TLR4-positive microglia were detected. However,
many activated TLR4-positive microglia/macrophages
(CD11b-positive cells) with large cell bodies and thick-
ened, short processes were observed post-trauma. These
Figure 1 TLR4−/− mice displayed attenuations in the neurological deficit and cell death. (A) A coronal brain slice showing an obvious
cavity (marked by an asterisk) in the injured cortex. The tissue examined in the experiment is marked by a box. (B) Time-dependent protein
expression of TLR4 in the injured tissue. (C) The neurological deficit score of TLR4−/− mice was significantly lower than that of wild-type (WT)
mice at 24 hours post-trauma. (D) Representative TUNEL-stained and 4',6-diamidino-2-phenylindole (DAPI)-stained brain sections at 24 hours
post-trauma. (E) Representative Fluoro-Jade B (FJB-stained) brain sections at 24 hours post-trauma. (F) Quantification analysis indicated that
TLR4−/− mice had significantly fewer TUNEL-positive cells in the pericontusional tissue than WT mice post-trauma. The percentage of TUNEL-
positive cells is expressed as the number of TUNEL-stained nuclei divided by the total number of DAPI-stained nuclei. (G) Quantification showed
that TLR4−/− mice had significantly fewer degenerating neurons than WT mice in the pericontusional tissue. The total number of FJB-positive cells
is expressed as the mean number per field of view. Values (mean ± SD) are representative of three independent experiments (n = 3 *P < 0.05,
**P < 0.01. Bar = 20 μm.
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reactivity (Figure 4A). The administration of 100 mg/kg
curcumin inhibited the increase in TLR4-positive micro-
glia/macrophages post-trauma (P < 0.05, Figure 4B),
although microglia/macrophages still exhibited reactive
morphology. Moreover, the concentrations of inflamma-
tory mediators (IL-1β, IL-6, TNF-α, MCP-1 andRANTES) in the injured brain tissue, determined using
ELISA, were significantly increased in the two TBI
groups when compared with the two sham groups
(P < 0.01), and these mediators were all dramatically
decreased in curcumin-treated mice when compared
with vehicle-treated mice, with the exception of IL-6
(P < 0.05, Figure 4C-G).
Figure 2 TLR4−/−mice displayed attenuated brain edema and neuroinflammation post-trauma. (A) TLR4−/− mice displayed decreased brain
water content compared with WT mice. ELISA showed a change in the release of IL-1β, IL-6, TNF-α, MCP-1 and RANTES (B, C, D, E, F) in TLR4−/−
mice brain tissue 24 hours post-trauma. Values (mean ± SD) are representative of three independent experiments (n = 3 mice/group).
*P < 0.05, **P < 0.01.
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TLR4/MyD88/NF-κB signaling pathway in vivo
Western blotting showed that TLR4 and MyD88 protein
expression in the injured tissue was increased dramatic-
ally in the TBI groups when compared with the sham
control groups (P < 0.01) and that it was significantly
lower in curcumin-treated mice than in vehicle-treated
mice at 24 hours post-trauma (P < 0.05, Figure 5A). NF-
κB p65 and p-IκB-α protein expression in the injured
tissue was also increased dramatically in the TBI groups
but was significantly decreased in curcumin-treated mice
compared to the vehicle-treated mice at 24 hours post-
trauma (P < 0.05, Figure 5B). In contrast, IκB-α protein
expression was decreased in the TBI groups but was sig-
nificantly increased in curcumin-treated mice when
compared with vehicle-treated mice at 24 hours post-
trauma (P < 0.05, Figure 5B).
Curcumin reduced neuronal damage induced by LPS
in vitro
To directly observe the interaction of microglia and neu-
rons, we used a transwell co-culture system including
primary neurons and microglia and stimulated the cells
with LPS. Microglia were plated onto the transparent
polyester membrane of the transwell inserts, and neu-
rons were placed on the wells below the polyester mem-
brane; as a result, the microglia grown on the transwells
were separated from the neuron-enriched cultures by
the permeable transwell membrane (Figure 6A). To de-
termine the optimal concentration of curcumin for
cell co-culture, 0.5, 1, 2, 5 and 10 μM were appliedseparately. The administration of 10 μM curcumin sig-
nificantly reduced microglial viability compared with the
no-curcumin control (P < 0.05), whereas the cell viability
in the 0.5, 1, 2 and 5 μM curcumin treatment groups did
not significantly differ from that in the control group
(p > 0.05, Figure 6B). However, 5 and 10 μM curcumin
both significantly reduced neuronal viability when com-
pared with the no-curcumin control (P < 0.05, Figure 6B).
Accordingly, 2 μM was chosen as the optimal concentra-
tion for the transwell co-culture system.
We then examined neuronal damage under various con-
ditions. The protein levels of cleaved caspase-3 in neurons
were significantly increased 24 hours after LPS stimulation
(P < 0.01), and the protein level in co-cultured neurons
was significantly higher than that in the single-culture
group (P < 0.05). In the co-culture groups, curcumin treat-
ment after LPS administration significantly decreased the
upregulation of cleaved caspase-3 (P < 0.05). In contrast,
in the single-culture groups, curcumin treatment after
LPS stimulation did not significantly decrease the upregu-
lation of cleaved caspase-3 (P > 0.05, Figure 6C). Similar
results were observed using immunofluorescence. At 24
hours after LPS administration, many neuronal bodies and
processes were destroyed or no longer evident, and more
serious neuronal damage was observed in the co-culture
group than in the single-culture group. However, when
the cells were treated with curcumin after LPS stimulation,
less serious neuronal damage was observed in the
co-culture groups, whereas no marked change in neuro-
nal damage was observed in the single-culture groups
(Figure 6D).
Figure 3 Curcumin attenuated brain injury post-trauma. (A) The effect of different concentrations of curcumin on TLR4 expression in injured
tissue at 24 hours post-trauma. Curcumin treatment decreased the neurological deficit scores (B) and brain water content (C). (D) Representative
TUNEL-stained and 4',6-diamidino-2-phenylindole (DAPI)-stained brain sections at 24 hours post-trauma. (E) Representative Fluoro-Jade B (FJB)-stained
brain sections at 24 hours post-trauma. (F) Quantification analysis indicated that curcumin-treated mice had significantly fewer TUNEL-positive cells
in the pericontusional tissue than vehicle-treated mice. The percentage of TUNEL-positive cells is expressed as the number of TUNEL-stained nuclei
divided by the total number of DAPI-stained nuclei. (G) Quantification showed that curcumin-treated mice had significantly fewer degenerating
neurons than vehicle-treated mice in the pericontusional tissue. The total number of FJB-positive cells is expressed as the mean number per field
of view. Values (mean ± SD) are representative of two independent experiments (n = 6 mice/group). *P < 0.05, **P < 0.01. Bar = 20 μm.
Zhu et al. Journal of Neuroinflammation 2014, 11:59 Page 8 of 17
http://www.jneuroinflammation.com/content/11/1/59Curcumin attenuated the microglial activation and
inflammatory mediator release induced by LPS in vitro
In the transwell co-culture experiments, LPS stimulation
induced a reactive state in the microglia, which was demon-
strated by a larger cell body and thickened, shorterprocesses, and these microglia also showed robust TLR4
immunofluorescence intensity. In contrast, in cells treated
with curcumin after LPS stimulation, a less reactive state of
the microglia and lower TLR4 immunofluorescence inten-
sity were observed (Figure 7A, B). We next characterized
Figure 4 (See legend on next page.)
Zhu et al. Journal of Neuroinflammation 2014, 11:59 Page 9 of 17
http://www.jneuroinflammation.com/content/11/1/59
(See figure on previous page.)
Figure 4 Curcumin decreased neuroinflammation and the activation of CD11b-positive cells co-labeled with TLR4 post-trauma. (A)
Representative CD11b-positive cells co-labeled with TLR4 in the pericontusional tissue at 24 hours post-trauma. (B) Quantification showed that
curcumin-treated mice had significantly fewer CD11b-positive cells co-labeled with TLR4 in the pericontusional tissue than vehicle-treated mice.
The total number of CD11b-positive cells co-labeled with TLR4 is expressed as the mean number per field of view. ELISA showed that curcumin
treatment resulted in a change in the release of IL-1β, IL-6, TNF-α, MCP-1 and RANTES (C, D, E, F, G) at 24 hours post-trauma. Values (mean ± SD)
are representative of two independent experiments (n = 6 mice/group). *P < 0.05, **P < 0.01. Bar = 20 μm.
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pernatants by ELISA. These mediators were all increased
dramatically 24 hours after LPS stimulation (P < 0.01), but
only IL-1β, IL-6 and RANTES were significantly decreased
in the curcumin-treated group compared with the vehicle-
treated group (P < 0.05, Figure 7C, D, G); the differences in
TNF-α and MCP-1 between the curcumin-treated groupFigure 5 Curcumin suppressed TLR4/MyD88/NF-κB signaling pathway
in the injured tissue was significantly lower in curcumin-treated mice than
p-IκB-α protein expression in the injured tissue was also significantly lower
post-trauma. In contrast, IκB-α protein expression was significantly higher in
Values (mean ± SD) are representative of three independent experiments (nand the vehicle-treated group were not significant following
LPS stimulation (P > 0.05, Figure 7E, F).
Curcumin suppressed microglial TLR4/MyD88/NF-κB
signaling pathway protein expression in vitro
To further understand the effect of curcumin treatment
on TLR4 downstream signaling pathways in microglia,protein expression in vivo. (A) TLR4 and MyD88 protein expression
in vehicle-treated mice at 24 hours post-trauma. (B) NF-κB p65 and
in curcumin-treated mice than in vehicle-treated mice at 24 hours
curcumin-treated mice than in vehicle-treated mice post-trauma.
= 3 mice/group). *P < 0.05, **P < 0.01.
Figure 6 Curcumin attenuated the neuronal damage induced by lipopolysaccharide (LPS) in the transwell co-culture of neurons and
microglia. (A) In a transwell system, microglia and neurons were cultured together, as shown. (B) Cell viability following the administration
of different concentrations of curcumin. (C) Protein level of cleaved caspase-3 in neurons in co-culture and single-culture systems. Curcumin
significantly reduced cleaved caspase-3 in the co-culture system after LPS stimulation. (D) Morphological changes of neurons in the single-culture
and co-culture systems. Curcumin attenuated morphological damage in the co-culture system after LPS stimulation but did not have an effect in
the single-culture system. Values (mean ± SD) are representative of three independent experiments. ΔP < 0.05, compared with the no-curcumin
treatment group for microglial viability; #P < 0.05, compared with the no-curcumin treatment group for neuronal viability; *P < 0.05, **P < 0.01.
Bar = 50 μm.
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of TLR4 and its adapter proteins at 24 hours post-
trauma. In the transwell co-cultures of primary neurons
and microglia stimulated by LPS, the levels of TLR4 and
MyD88 protein expression in microglia were signifi-
cantly increased compared with those in the two controlgroups (P < 0.01); further, they were significantly de-
creased in the curcumin-treated group compared with
the vehicle-treated group following LPS stimulation
(P < 0.05, Figure 8A). Similar changes in p-IκB-a and
NF-κB p65 were observed. In contrast, IκB-a protein
expression was significantly decreased in the two LPS-
Figure 7 (See legend on next page.)
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Figure 7 Curcumin reduced microglial activation and inflammatory mediator release induced by lipopolysaccharide (LPS) in the
transwell co-culture of neurons and microglia. (A) Colocalization of CD11b and TLR4 was evident. Treatment with curcumin after LPS
stimulation resulted in a less reactive state of the microglia, as shown. (B) TLR4 immunofluorescence intensity in microglia was also reduced
after curcumin treatment. ELISA showed that curcumin-treated cells had a change in the release of IL-1β, IL-6, TNF-α, MCP-1 and RANTES
(C, D, E, F, G) at 24 hours after LPS administration. Values (mean ± SD) are representative of three independent experiments. *P < 0.05, **P < 0.01.
Bar = 50 μm.
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groups (P < 0.05) and was significantly increased in the
curcumin-treated group when compared with the vehicle-
treated group following LPS stimulation (P < 0.05, 8B).
Discussion
In this study, we used TLR4−/− mice to investigate the
role of TLR4 during the acute stage of TBI and observed
reductions in cerebral edema, neurological deficit and
neuronal apoptosis at 24 hours post-injury in TLR4−/−
mice compared with WT mice. We administered curcu-
min (100 mg/kg) to WT mice after TBI and observed
decreases in microglia/macrophages, inflammatory fac-
tor release, neurological deficit and neuronal apoptosis
at 24 hours post-injury by inhibiting the TLR4/MyD88/
NF-κB signaling cascade. In vitro, in a co-culture system
of microglial and neuronal cells, LPS administration in-
duced microglial activation and neuronal damage, while
2 μM curcumin could inhibit microglial activation and
neuronal apoptosis by suppressing the microglial TLR4
signaling pathway. To our knowledge, we report for the
first time that one possible molecular mechanism
whereby curcumin attenuates brain injury is the modula-
tion of acute neuroinflammation mediated by the TLR4/
MyD88/NF-κB signaling pathway in microglia/macro-
phages during experimental TBI.
One key factor in secondary brain injury is a complex
series of inflammatory responses that is initiated largely
through TLRs that possibly interact with endogenous li-
gands released from damaged cells [32,33]. Furthermore,
TLR4, which is widely expressed on the plasma mem-
branes of neural cells, has been demonstrated to play an
important role in initiating the cerebral inflammation
related to cerebral ischemia-reperfusion injury and intra-
cerebral hemorrhage in TLR4−/− mice [34,35]. Along
these lines, neuroinflammatory responses initiated by
TLR4 may also be an important factor underlying sec-
ondary brain injury after TBI. Indeed, TLR4 protein ex-
pression was significantly increased at six hours after
brain trauma and remained high at 72 hours compared
with the levels observed in the control group in our
study, which is consistent with the report of Chen and
colleagues [36]. Furthermore, a critical role of TLR4 was
demonstrated by our observations that brain water con-
tent, neurological deficit score and neuronal death were
significantly decreased in TLR4−/− mice in comparisonto WT mice suffering a similar severity of head trauma.
The neuroprotective effect of TLR4 deficiency in TBI
can be partially attributed to the suppression of acute
neuroinflammation induced by the inhibition of micro-
glial or peripheral leukocyte activation and the subse-
quent cytokine release. In Helmy’s clinical study, the
release of many cytokines, such as IL-1β, TNF-α and
RANTES, peaked at 24 hours post-trauma, and notably,
the concentrations of some cytokines (for example, IL-
1β, IL-6, MCP-1) were significantly higher in brain tissue
than in plasma [37]. In the present study, the upregula-
tion of IL-1β, IL-6, MCP-1 and RANTES in injured brain
tissue was dramatically attenuated in injured TLR4−/−
mice, although TNF-α was not significantly decreased.
Some anti-inflammatory therapies aimed at inhibiting
TLR4 activation have displayed neuroprotective effects at
24 hours in animal TBI models [38,39]. Recently, another
study of TBI, which showed lower infarct volumes and
better outcomes on neurological and behavioral tests in
TLR4−/− mice at 24 hours post-injury, has also validated
the important role of TLR4 in TBI [10].
We focused on curcumin, which is used as a spice or
a pigment, because of its numerous pharmacological
activities, very low toxicity and widespread availability.
Unfortunately, curcumin exhibits relatively poor oral
bioavailability and a short serum half-life (< 45 minutes),
which could contribute to its limited therapeutic window
(less than one hour post-injury) in head trauma [17,40].
One study reported that in mice, peak plasma concen-
trations (approximately 1.6 μM) were achieved 15
minutes after the intraperitoneal administration of 100
mg/kg curcumin, followed by brain accumulation within
one hour [41]. A much better curcumin bioavailability
has been reported in many articles following intraperito-
neal injection [41-43]. Thus, we chose an intraperitoneal
injection at 15 minutes post-trauma in our study be-
cause of the better bioavailability and the limited effect-
ive window of curcumin. A 100 mg/kg dose was selected
due to its dramatic reduction of TLR4 expression at 24
hours and the relatively low concentration in the three
different concentrations administered to mice. In
addition, the use of liposomes or nanoparticles may im-
prove drug delivery, overcome bioavailability issues and
extend the therapeutic window [40].
In TBI experiments, cognitive disability tested by the
Morris water maze has been ameliorated by treatment
Figure 8 Curcumin suppressed the expression of proteins in the microglial TLR4/MyD88/NF-κB signaling pathway in co-culture system.
(A) TLR4 and MyD88 protein expression in microglia was significantly lower in the curcumin-treated group than in the vehicle-treated group
at 24 hours after lipopolysaccharide (LPS) stimulation. (B) NF-κB p65 and p-IκB-α protein expression in microglia was also significantly lower in
the curcumin-treated group than in the vehicle-treated group at 24 hours following LPS stimulation. In contrast, IκB-α protein expression was
significantly higher in the curcumin-treated group than in the vehicle-treated group after LPS stimulation. Values (mean ± SD) are representative
of three independent experiments. *P < 0.05, **P < 0.01.
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nitive protection conferred by curcumin is partially re-
lated to the restoration of membrane homeostasis or to
normalized levels of brain-derived neurotrophic factor
(BDNF) and its downstream effectors of synaptic plasti-
city (cAMP-response element binding protein, synap-
sin1). In addition to the cognitive functions described
above, locomotor function and brain edema have also
been improved with curcumin treatment due to the de-
crease in the induction of NF-κB and its downstream
production of IL-1β in the brain [17]. In mice with intra-
cerebral hemorrhage, the attenuation of hematoma size
and neurological injury was also associated with thedecreased induction of cytokine expression after curcu-
min treatment [45]. These findings suggest that immune
modulation by curcumin is a promising approach to the
treatment of brain injury. Furthermore, TLR4, a critical
membrane receptor mediating innate immunity, can in-
duce NF-κB upregulation when it is activated by stimuli
[46]. Therefore, for immunomodulation following TBI,
TLR4 may be an important target of curcumin. Notably,
Youn et al. have demonstrated that the TLR4 receptor
complex is a molecular target of curcumin and that cur-
cumin can inhibit TLR4 homodimerization [20]. In the
present study, the upregulation of TLR4 expression and
inflammatory mediator release (IL-1β, TNF-α, MCP-1
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following TBI. Among these mediators, RANTES has
been suggested as a significant early marker of severe
TBI in critically injured trauma patients [47]. Further-
more, the curcumin-treated group, which exhibited sup-
pressed acute inflammatory responses after TBI, showed
ameliorated brain damage, including reduced neurological
impairment, brain edema and neuronal and apoptotic cell
death. Thus, curcumin could reduce TLR4-mediated post-
traumatic acute neuroinflammation, thereby attenuating
secondary brain injury. A few studies have also reported
that curcumin can attenuate inflammation and subsequent
inflammatory injury by inhibiting TLR4 expression in col-
itis [48], hepatic fibrosis [49] and lung injury [50]. Within
the TLR4 signaling pathway, the MyD88-dependent sig-
naling pathway is an important activator of NF-κB and the
subsequent regulatory effects of NF-κB signaling [51,52].
In accordance with these reports, the levels of MyD88 and
NF-κB were observed to decrease following curcumin ad-
ministration. These data suggest that the protective effects
of curcumin on the brain against excessive inflammatory
responses may be mediated by the TLR4/MyD88/NF-κB
signaling cascade following TBI.
Microglia, which when activated by exogenous or en-
dogenous ligands produce a number of proinflammatory
cytokines implicated in neurotoxicity, are the principal
cells involved in the innate immune response in the
CNS [53]. In the present study, CD11b-positive cells
were reduced in injured brain tissue following curcumin
treatment. However, CD11b positivity does not imply
that these cells are exclusively microglia; CD11b-positive
cells can also include monocytes/macrophages and lym-
phocytes, which permeated the injured tissue. Peripheral
immune infiltration and alterations can also have a sig-
nificant impact in TBI [54]. However, microglia were our
primary interest, and we therefore used a transwell co-
culture system with microglia and neurons to further in-
vestigate the role of microglia in immunomodulation.
In our experiments in vitro, LPS resulted in obvious
neuronal damage in both the single-culture and co-culture
systems. However, the observation that the damage was
more serious in neurons co-cultured with microglia indi-
cates that microglia play an important role in neuronal
injury. This was consistent with another report [55], in
which low concentrations of LPS induced significant
neuronal death in a co-culture system that allowed direct
microglial-neuronal contact; however, high concentrations
of LPS were necessary to induce neurotoxicity in a trans-
well system permitting only cell contact-independent
communication. Nevertheless, the critical role of microglia
in neuronal damage was evident.
Curcumin treatment dramatically alleviated neuronal
damage in the co-culture system but had no obvious ef-
fect in neuron-only cell culture after LPS stimulation.These results suggest that the protective effect of curcu-
min on neurons was mediated through microglia. Simi-
larly, a previous study showed that curcumin protected
dopaminergic neurons from MPP+-induced neurotoxicity
in rat mid-brain neuron-glia co-cultures and that the
protective effect of curcumin disappeared in microglia-
depleted cultures [56]. Furthermore, curcumin had an
inhibitory effect on microglial migration in a BV-2 cell
scratch model and transwell migration model [57]. The
TLR-induced activation of microglia and the release of
proinflammatory molecules are responsible for neurotoxic
processes in the course of some CNS diseases [58,59]. In
the present transwell co-culture system, curcumin treat-
ment inhibited TLR4 expression in microglia, the mor-
phological activation of microglia and inflammatory
mediator release following LPS stimulation, and these
findings are consistent with the observed attenuated neur-
onal damage. These in vitro observations suggest that the
inhibition of microglial TLR4 may be one reason under-
lying the suppression of neuroinflammation and the pro-
tection of neurons following curcumin treatment. In
regard to the TLR4 pathway, one study reported that a
functional TLR4/MyD88 cascade in microglia was essen-
tial for neuronal injury induced by HSP60 via the
co-culture of WT neurons with MyD88−/− or Lpsd micro-
glia (hyporesponsiveness to LPS as a consequence of a
point mutation rendering the cytosolic domain of TLR4
incapable of signal transduction) [60]. In another study of
rat vascular smooth muscle cells (VSMCs), curcumin sup-
pressed the LPS-induced overexpression of inflammatory
mediators in VSMCs by inhibiting the TLR4/NF-κB path-
way [24]. In our co-culture system including primary WT
neurons and microglial cells, the protein levels of TLR4
and downstream molecules (MyD88, p-IκB-α and NF-κB)
in microglia were increased by LPS, and curcumin attenu-
ated the upregulation of these molecules in the TLR4
pathway. These data further indicate that curcumin regu-
lates a complex series of inflammatory responses contrib-
uting to neuronal damage, in part through the microglial
TLR4/MyD88/NF-κB signaling pathway.
Interestingly, in contrast to LPS administration after
brain injury, LPS preconditioning protected the brain
from ischemic injury through the redirection of TLR4
signaling, including the suppression of NF-κB activity,
enhancement of interferon regulatory factor 3 (IRF3)
activity and an increase in anti-inflammatory/type I
interferon gene expression [61,62]. In TBI, LPS precon-
ditioning has also been shown to confer a long-lasting
neuroprotective effect associated with the modulation of
microglia/macrophage activity and cytokine production
[63]. In a study of cold-induced cortical injury, micro-
glial activation in response to peripheral LPS precondi-
tioning largely depended on nonhematogenous TLR4
receptors, and these activated microglia resulted in
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tion [64]. The role of the microglial TLR4 signaling
pathway in this type of neuroprotection warrants further
investigation. Notably, immune modulation by curcumin
is robust, and the TLR4 signaling pathway may not be
an exclusive mechanism through which curcumin mod-
ulates neuroinflammation and contributes to secondary
brain injury. However, modulation of the TLR4 pathway
was undeniably critical for the neuroprotection mediated
by curcumin post-TBI.
In conclusion, our findings demonstrated a critical role
for TLR4 of microglia/macrophages in acute neuroin-
flammation following TBI. Post-injury treatment with
curcumin attenuated TLR4-mediated acute activation of
microglia/macrophages, proinflammatory mediator release
and neuronal apoptosis in the injured brain tissue via in-
hibition of the MyD88/NF-κB signaling cascade, and this
may be an important mechanism through which curcumin
improves outcome following TBI. All the data support
modulation of the TLR4/MyD88/NF-κB signaling pathway
in microglia/macrophages as a potential therapeutic target
in TBI and suggest that curcumin should be considered a
candidate for clinical trials in TBI.
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